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ABSTRACT Intracellular acidosis is a profound nega-
tive regulator of myocardial performance. We hypothe-
sized that titrating myofilament calcium sensitivity by a
single histidine substituted cardiac troponin I (A164H)
would protect the whole animal physiological response to
acidosis in vivo. To experimentally induce severe hyper-
capnic acidosis, mice were exposed to a 40% CO2 chal-
lenge. By echocardiography, it was found that systolic
function and ventricular geometry were maintained in
cTnI A164H transgenic (Tg) mice. By contrast, non-Tg
(Ntg) littermates experienced rapid and marked cardiac
decompensation during this same challenge. For detailed
hemodymanic assessment, Millar pressure-conductance
catheterization was performed while animals were trea-
ted with a-blocker, esmolol, during a severe hypercapnic
acidosis challenge. Survival and load-independent mea-
sures of contractility were significantly greater in Tg vs.
Ntg mice. This assay showed that Ntg mice had 100%
mortality within 5 min of acidosis. By contrast, systolic and
diastolic function were protected in Tg mice during
acidosis, and they had 100% survival. This study shows
that, independent of any -adrenergic compensation,
myofilament-based molecular manipulation of inotropy
by histidine-modified troponin I maintains cardiac inotro-
pic and lusitropic performance and markedly improves
survival during severe acidosis in vivo.—Palpant, N. J.,
D’Alecy, L. G., Metzger, J. M. Single histidine button in
cardiac troponin I sustains heart performance in response
to severe hypercapnic respiratory acidosis in vivo. FASEB J.
23, 1529–1540 (2009)
Key Words: myocardial function  myofilaments  pH
Acute heart failure can result from myocardial
acidosis. Myocardial acidosis arises from reduced
plasma oxygen tension (hypoxic acidosis), as in cases
of myocardial ischemia (1, 2), or accumulated levels
of plasma carbon dioxide (hypercapnic acidosis or
hypercarbia), found with severe pulmonary diseases
such as chronic obstructive pulmonary disease
(COPD) (3) or emphysema (4). Acidosis has numer-
ous pathophysiological implications within the con-
text of many organ systems, including significant
deleterious effects on the contractile function of the
heart (5–9). Homeostasis is tightly regulated in the
heart, which makes this organ particularly sensitive to
whole-animal metabolic changes and the down-
stream influence on pH status and energy availability
(10, 11).
There are numerous changes that occur in the
heart under conditions of acidosis, including altered
excitation-contraction coupling (8, 10, 12–15). The
present study focused on altered sarcomeric protein
function known to significantly reduce cardiac con-
tractility during acute acidosis independent of al-
tered Ca2 handling (6, 16, 17). A key regulator of
myofibrillar contraction is the troponin complex,
including the calcium binding subunit, troponin C
(TnC), and the inhibitory subunit, troponin I (TnI).
Calcium increases the TnI-TnC interaction, causing
these subunits to act as a dynamic switch within the
myofilament during systole and diastole. Acidosis
diminishes myofilament Ca2 sensitivity, due in part
to reduced Ca2 binding to troponin C (6, 18), and
impaired interactions between TnI and TnC during
systole. Thus, this complex serves as a key regulator
of beat-to-beat contractility in the heart (19). In the
whole heart, this reduction in myofilament Ca2
sensitivity is a key contributor to the reduction in
acute myofilament force production and a conse-
quent decrement in left ventricular developed pres-
sure in vivo (20, 21).
Earlier biochemical studies established that neonatal
myocardium is more resilient to low pH (7), a pheno-
type correlated with fetal expression of the slow skeletal
isoform of TnI. The ssTnI isoform is better able to
retain proper myofibrillar contractility during acidosis
(22–29). Specifically, the pCa (log[Ca2]) required for
50% activation of myofilaments in adult cardiac myocytes,
which express the adult isoform of TnI (cTnI), drops by
more than 1 pCa units during acidification of pH (from
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pH 7.0 to 6.2). This is compared to adult myocytes
transduced with an adenoviral construct expressing the
slow skeletal isoform of TnI (ssTnI), which show an
attenuated pCa shift during acidification of pH (from
pH 7.0 to 6.2) (24). Several studies have further
demonstrated that the unique biochemistry of ssTnI
can be reproduced in the adult TnI isoform (cardiac
TnI) by substituting a single histidine residue for
alanine at codon 164 (27–31). This modification is
located at the interface between TnC and actin
binding domains involved in the switch function of
TnI. We have generated a murine transgenic mouse
model wherein this histidine button has been engi-
neered into the adult cardiac isoform of TnI (cTnI
A164H) under control of the -myosin heavy-chain
promoter. This provides a biophysical basis for a
functional molecular rheostat of intracellular pH in
the adult heart (9, 20). Cellular data have shown that
myocytes expressing cTnI A164H have intact re-
sponses to isoproterenol and PKA by hastening re-
laxation kinetics and shifting the tension-pCa relation-
ship (20). Furthermore, calcium load is diminished in
these myocytes, which is manifest in a lower calcium
transient amplitude (20, 32). Studies of transgenic (Tg)
mice expressing this engineered mutant cTnI show im-
proved cardiac inotropic function in response to a variety
of pathophysiological challenges, including acute and
chronic ischemia (20), as well as in a mouse model of
age-induced cardiomyopathy (32).
The current study focused exclusively on the in vivo
whole animal response to acidosis in the context of
this modified cTnI using an experimental model of
severe respiratory hypercapnia. A major aim of this
study was to block adrenergic support in the heart
and subsequently analyze cardiac function in vivo
under baseline conditions and during exposure to
acidosis. Adrenergic stimulation is a major regulator
of cardiac function at baseline in the rodent (20, 22).
Furthermore, high sympathetic stimulation of rodent
hearts at baseline has been shown to compensate and
mask cardiomyopathic phenotypes that are revealed
during suppression of catecholamine signaling (33).
In light of this, -blockade in mouse models consist-
ing of myofilament modifications (20, 34, 35) is of
particular importance for determining any func-
tional aberrations caused by altered myofilament
calcium responsiveness on systolic and diastolic per-
formance. Furthermore, -blockade allows for the
functional readout of intrinsic inotropic perfor-
mance of the heart in vivo, which is important in
determining the potential for cardiac contractile
responsiveness to injury. These questions have not
been addressed in the cTnI A164H Tg mouse to date.
The new findings of this study show that cTnI A164H
preserves systolic and diastolic performance during
acidosis in vivo. This study suggests that the biochem-
ical function of cTnI A164H as a molecular rheostat
in the sarcomere may protect cardiac performance in
a range of pathologies associated with acidosis.
MATERIALS AND METHODS
Mouse model
Generation and analysis of Tg mice expressing a histidine-
modified cardiac troponin I (cTnI A164H) with FLAG
epitope were previously described (20). The procedures
used in this study are in agreement with the guidelines of
the University of Michigan and approved by the University
of Michigan Committee on the Use and Care of Animals.
Veterinary care was provided by the University of Michigan
Unit for Laboratory Animal Medicine. The University of
Michigan is accredited by the American Association of
Accreditation of Laboratory Animal Health Care, and the
animal care use program conforms to the standards of the
U.S. National Institutes of Health (NIH) Guide for the
Care and Use of Laboratory Animals (NIH Pub. No.
85–23).
Conductance micromanometry
Measurements of in vivo cardiovascular hemodynamics
were obtained using conductance micromanometry, as
previously performed by this laboratory (20). Mice were
anesthetized and ventilated via a tracheal cannulation and
ventilated via a pressure-controlled ventilator with 1%
isoflurane at a peak inspiratory pressure of 15 cm H2O and
a respiratory rate of 60 breaths/min. With the aid of a
dissecting microscope, the heart was exposed via a thora-
cotomy. A 1.4 French Millar pressure-volume catheter
(PVR-1045; Millar Instruments, Houston, TX, USA) was
then placed into the left ventricular chamber via an apical
stab. Left ventricular pressure and volume measurements
were collected at a sampling rate of 1 kHz. Data were
analyzed with Ponemah software, P3 Plus (DSI Interna-
tional, St. Paul, MN, USA). Transient inferior vena cava
(IVC) occlusions were also performed to obtain the end-
systolic and end-diastolic pressure-volume relationships.
IVC occlusions were performed at baseline and at 5 min of
esmolol infusion (Fig. 3a). After obtaining baseline hemo-
dynamics (ventilated with isoflurane and O2), mice re-
ceived a continuous infusion of esmolol (250 g/kg/min)
that continued until the completion of the assay. After 5
min of esmolol infusion, mice were exposed to an acute
hypercapnic acidosis challenge (40% CO2 balanced with
oxygen) (for schematic diagram of protocol, see Supple-
mental Fig. 3). Data were acquired until systolic failure,
which was defined as the point when peak left ventricular
systolic pressure dropped to 50 mmHg. At this point,
esmolol infusion was stopped, and mice were revived using
100% O2 in order to obtain instrument calibration.
Echocardiography
Anesthesia was induced with 3% isoflurane and then
maintained at 1% for the duration of the procedure. The
hair was removed from the upper abdominal and thoracic
area with depilatory cream. Electrocardiography (ECG)
was monitored via noninvasive resting ECG electrodes.
Transthoracic echocardiography was performed in the
supine or left lateral position. Two-dimensional, M-mode,
Doppler, and tissue Doppler echocardiographic images
were recorded using a VisualSonics’ Vevo 770 high-resolu-
tion in vivo microimaging system (VisualSonics Inc., To-
ronto, ON, Canada). The systolic and diastolic dimensions
and wall thickness were measured in M mode in the
parasternal short-axis view at the level of the papillary
muscles (36, 37). Fractional shortening and ejection frac-
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tion were calculated from the M-mode parasternal short-
axis view (37). Diastolic function was assessed by conven-
tional pulsed-wave spectral Doppler analysis of mitral valve
inflow patterns [early (E) and late (A) filling waves].
Doppler tissue imaging (DTI) was used to measure the
early (Ea) and late (Aa) diastolic tissue velocities of the
lateral annulus. As a combined measure of systolic and
diastolic function, the TEI index was measured as
(LVctetrtLVet)/LVctetrt, in which LVctetrt is the total time
of left ventricular contraction, ejection plus relaxation and
LVet is left ventricular ejection time. After acquiring base-
line echocardiographic data, mice were exposed to a
hypercapnic acidosis challenge (ventilation with 40% CO2
balanced with oxygen) for 10 min. During ventilation with
CO2, efforts were taken to confirm that the nose and
mouth were within the nose cone to prevent any dilution of
the inhaled gas due to gasping of room air. Data were
acquired every 2.5 min for the duration of the challenge.
All mice survived this challenge and were returned to their
cage for recovery.
In vivo arterial pressure and ECG telemetry
Implantable radiotelemetry probes (C-10 implants; DSI
International, St. Paul, MN, USA) for measurement of
real-time systemic blood pressure and ECG in freely mov-
ing unanesthetized animals was accomplished, as described
previously (38 – 40). One week after implantation of telem-
etry probe, mice were placed in a flow-through chamber
initially flushed with room air (20.93% O2), allowing
rodents time to equilibrate to the new environment. They
were then exposed to a hypercapnic acidosis challenge (40
min exposure to 40% CO2 balanced with oxygen). On
completion of the challenge, mice were removed from the
chamber and returned to their cage for recovery.
Blood gas analysis
Mice were anesthetized with 1% isoflurane and exposed to
a hypercapnic acidosis challenge (40% CO2 balanced with
oxygen) for 10 min without external ventilator support. A
second cohort of Tg mice was also exposed to a hypercap-
nic acidosis challenge for 20 min. During ventilation with
CO2, efforts were taken to confirm that the nose and
mouth were within the nose cone to prevent any dilution of
the inhaled gas due to gasping of room air. At the end of
the challenge the thoracic cavity was opened to expose the
heart. Approximately 600 l of oxygenated blood was
drawn from the left ventricle and immediately analyzed
using a Radiometer ABL505 blood gas analyzer (Radiome-
ter, Westlake, OH, USA).
Statistics
All results are expressed as means  se. All single variable
assays were assessed by two-tailed t test. All multivariable
assays were assessed using either one-way analysis of vari-
ance (ANOVA) or two-way repeated-measures ANOVA with
Tukey post hoc test. Survival after the in vivo acute hyper-
capnic acidosis challenge was assessed by the Fisher exact
test.
RESULTS
Echocardiography assessment during acute
respiratory hypercapnic acidosis
Using echocardiography to track in vivo left ventric-
ular function, Tg mice retained global cardiac per-
formance and proper left ventricular dimensions
during exposure to acidosis. By contrast, nontrans-
genic (Ntg) mice showed significant myocardial con-
tractile dysfunction throughout the same challenge
(Fig. 1). In addition to the summarized echo data (Fig.
1b, c), Table 1 shows changes in cardiac function at the
end of the challenge compared to measurements taken
at the beginning and at the nadir for each parameter.
We found that the function of Tg hearts at the end of
the challenge was not significantly different from base-
line based on a repeated-measures one-way ANOVA. In
contrast, the lowest point of function for Ntg mice was
at the end of the challenge in all cases, or the nadir to
the end of the challenge was not significant from 0
based on a Dunnet’s test.
In addition to being mildly hypercontractile at
baseline, echocardiography data showed evidence of
a modest decrease during the early stages of the
acidosis challenge, which reverted by the 10-min time
point in Tg mice. At the end of the challenge, aspects
of Tg heart performance were not significantly dif-
ferent from baseline [e.g., Tg ejection fraction (EF)
at baseline: 75.14.7 vs. 68.15.7% after 10 min of
acidosis; NS] (Fig. 1b, c). By contrast, Ntg mice
showed a significant reduction in cardiac contractil-
ity throughout the challenge (e.g., EF at 10 min of
acidosis: 23.64.9 vs. 67.84.5% for Ntg and Tg;
P0.05) (Fig. 1b, c; Supplemental Fig. 1). Further-
more, Tg mice retained ventricular geometry during
the hypercapnic acidosis challenge compared to Ntg
mice that underwent significant left ventricular cavi-
tary dilation (e.g., LV dimensions at systole at 10 min
of acidosis: 17.31.2 vs. 9.31.3 mm for Ntg and Tg;
P0.05) (Fig. 1b, c). As a measure of diastolic func-
tion, the mitral valve inflow velocity (MV E), mea-
sured by Doppler, recovered to baseline function
after the nadir in Tg mice compared to Ntg mice, in
which compromised diastolic function persisted
throughout the acidosis challenge (MV E change
from nadir to end in Tg mice: 262.581.7 mm/s)
(Table 1). Lastly, as an assessment of overall diastolic
and systolic function, the TEI index indicated that Tg
mice underwent an initial phase of cardiac decom-
pensation during the onset of acidosis but were able
to recover function by the end of the challenge
compared to Ntg mice, which showed persistent
cardiac dysfunction throughout the hypercapnic ac-
idosis challenge (TEI index at 10 min of acidosis:
0.620.05 vs. 0.50.03 for Ntg and Tg; P0.05)
(Supplemental Fig. 1). All mice recovered from this
hypercapnic acidosis challenge.
Blood gas analysis during acidosis
To assess whether there were any differences in blood gas
parameters during the acidosis challenge, arterial blood
gases were analyzed during hypercapnic acidosis. These
data indicate that, although significantly different from
baseline values, blood gases taken at 10 min of exposure
to 40% CO2 were not different between Tg and Ntg mice
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(Table 2). In both Tg and Ntg mice, blood pH decreased
from 7.2 at baseline to below 6.63 during the hypercapnic
challenge, demonstrating the development of significant
acidemia. This is consistent with changes in pCO2 which
increased from baseline values at 55 to 60 mmHg to250
mmHg during acidosis in both Tg and Ntg animals. This
increase in carbon dioxide was also confirmed in mea-
sures of total plasma CO2 that were significantly increased
during the hypercapnic challenge. Although oxygen avail-
ability during acidosis was increased from room air values
(60% compared to 	21%, respectively), oxygen satura-
tion tended to decrease from baseline values of 102% to
below 88% during hypercapnia, although this trend did
not reach statistical significance for either group. Lastly,
plasma concentrations of titratable base (SBEc) were
significantly reduced (P0.05) during hypercapnia com-
pared to baseline values, which is consistent with aci-
demia. There were no significant changes in plasma
bicarbonate during ventilation with 40% CO2, indicating
that these mice were not experiencing metabolic acidosis.
Blood gas analysis was also performed on Tg mice
after 20 min of exposure to 40% CO2. Changes in pH
indicate that the blood continued to acidify to a degree
significantly lower than the pH reached after 10 min of
hypercapnic acidosis (serum pH 6.620.02 vs.
6.550.00 at 10 and 20 min; P0.05). Furthermore,
SBEc continued to decrease concomitant with the de-
crease in blood pH. These findings are consistent with
the development of an increasingly severe respiratory
hypercapnic acidemia. However, even at 20 min expo-
sure to 40% CO2, plasma bicarbonate remained steady,
indicating the absence of any metabolic acidosis.
Blood pressure and ECG telemetry in vivo during
hypercapnic acidosis challenge
In vivo continuous arterial pressure telemetry of freely
moving unanesthetized animals was carried out be-
tween Ntg and Tg mice. Furthermore, this study ana-
Figure 1. Cardiac function assessed by echocardiography at baseline and during acidosis. a) Left panels: representative M-mode
echocardiographic images along the parasternal short-axis view showing changes in contractility of Ntg and Tg mice at baseline
and after 10 min of exposure to 40% CO2. White bars delineate systole and diastole. Time bar 
 100 ms; distance bar 
 2 mm.
Right panels: representative conventional pulsed-wave spectral Doppler analysis of mitral valve inflow and aortic valve outflow
patterns at baseline and after 10 min of exposure to 40% CO2 in Ntg and Tg mice. Time bar
 100 ms; flow rate bar
 40 cm/s.
b) Summarized mean data showing changes in cardiac functional parameters, including ejection fraction, left ventricular (LV)
dimensions at systole and diastole, and stroke volume between Ntg (F) and Tg (E) mice during the time course of hypercapnic
acidosis. c) Mean data showing the difference in ejection fraction, LV dimensions at systole, and stroke volume after 10 min exposure
to 40% CO2 (top) as well as the change () in function from baseline (bottom) in Ntg (f) and Tg () mice. Values are expressed
as means  se. Two-way repeated-measures ANOVA main effects: ‡P  0.05 for time; †P  0.05 for genotype. Two-way repeated
measures ANOVA interaction effects: §P  0.05 for time vs. genotype; *P  0.05 for Ntg vs. Tg. Ntg, n 
 5; Tg, n 
 7.
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lyzed the extent to which cTnI A164H mice were able to
maintain systemic perfusion pressures during a pro-
longed hypercapnic acidosis challenge (40 min expo-
sure to 40% CO2) compared to Ntg littermates (Fig. 2).
At baseline, circadian rhythms showed changes in
blood pressure over 24 h indicating that Ntg mice had
increased systolic blood pressure compared to Tg mice
(P0.05). However, diastolic arterial pressure was not
different between groups. Furthermore, these teleme-
tered data showed that Ntg mice also had a higher
baseline heart rate than Tg mice (472.215.6 vs.
555.418.7 for Tg and Ntg; P0.05) (Fig. 2a, b).
After 1 wk of baseline blood pressure measurements,
mice were exposed to a 40-min hypercapnic acidosis
challenge. The change in arterial systolic pressure be-
tween baseline (average daytime systolic pressure) and
the initial exposure to high flow 40% CO2 indicated that
both Ntg and Tg mice had a significant increase in blood
pressure in response to this challenge (Fig. 2c, d). This can
be attributed as an indirect measure of whole animal
adrenergic stimulation during this challenge in both
groups. Furthermore, cTnI A164H mice had significantly
higher systolic and diastolic arterial pressures during the
acidosis challenge compared to Ntg littermates (e.g.,
MAP81.518.4 vs.37.76.3 mmHg for Ntg and Tg;
P0.05) (Fig. 2c, e, and F).
TABLE 1. Changes in cardiac function during acidosis
Parameter Baseline Nadir End Nadir to end
Echocardiography
Tg
EF (%) 62.2  4.4 47.4  7.6# 67.8  4.5† 20.4  4.8*
Vol s (l) 19.7  3.3 24.4  4.9# 14.4  3.4† 10.1  2.9*
TEI index 0.4  0.03 0.6  0.04# 0.5  0.03†,‡ 0.1  0.0*
MV E (mm/s) 883.8  24.4 541.1  63.0# 803.6  36.6† 262.5  81.7*
Ntg
EF (%) 55.0  4.1 23.6  4.9# 23.6  4.9‡ 0.0  0.0
Vol s (l) 27.0  2.6 45.8  2.4# 40.6  5.1‡ 5.1  5.9
TEI index 0.40  0.02 0.65  0.03# 0.62  0.05‡ 0.03  0.07
MV E (mm/s) 1069.7  57.1 646.6  146.7# 646.6  146.7‡ 0.0  0.0
Hemodynamics
Tg
CI (dP/dt/mmHg) 196.9  9.6 113.1  2.4# 126.4  6.7‡ 12.2  6.5*
Max vol (l) 27.3  4.1 36.3  5.0# 32.5  5.0‡ 3.8  1.2*
EDp (mmHg) 6.2  1.1 12.3  1.8# 7.9  1.8† 4.4  0.8*
Ea (ESp/SV) 5.4  0.6 8.4  0.4
# 6.2  0.7† 2.2  0.6*
Ntg
CI (dP/dt/mmHg) 169.0  26.6 95.7  5.7# 0.0  0.0 —
Max vol (l) 28.1  5.4 55.1  5.5# 0.0  0.0 —
EDp (mmHg) 4.0  1.0 10.8  1.7# 0.0  0.0 —
Ea (ESp/SV) 6.2  0.4 14.2  2.5# 0.0  0.0 —
Analysis of cardiac function during acidosis in Tg and Ntg mice showing changes between baseline, nadir (worst value for a given
parameter), and end of challenge. All values are expressed as means  se. Echocardiographic parameters: ejection fraction (EF), volume at
systole (vol s), TEI index, and inflow velocity of mitral valve E wave (MV E). Tg, n
 7; Ntg, n
 5. Hemodynamic parameters: contractility index
(CI), left ventricular maximum volume (max vol), end diastolic pressure (EDp), and arterial elastance (Ea). Tg, n 
 7; Ntg, n 
 6. *P  0.05
vs. a hypothetical zero; Dunnets one-sample t test with Wilcoxon signed-rank post hoc. #P  0.05 vs. baseline, †P  0.05 vs. nadir, ‡P  0.05 vs.
baseline; repeated-measures one-way ANOVA.
TABLE 2. Arterial blood gas analysis
Parameter Ntg baseline Ntg CO2 (10 min) Tg baseline Tg CO2 (10 min) Tg CO2 (20 min)
pH 7.2  0.02 6.61  0.01* 7.2  0.0 6.62  0.02# 6.55  0.0†,‡
pCO2 (mmHg) 55.3  1.8 258.6  13.6* 59.1  2.9 265.7  8.5
# 277.3  14.5‡
pO2 (mmHg) 383.6  69.6 196.9  43.9 296.8  60.4 206.5  38.7 301.0  15.2
sO2 (%) 102.9  1.0 87.7  5.1 102.4  1.0 86.2  6.4 94.9  3.6
HCO3
 (mM) 23.5  0.7 24.4  0.9 23.1  1.1 25.8  0.6 23.2  0.5
tCO2 (vol %) 56.5  1.6 72.5  2.7* 55.6  2.6 76.0  1.4
# 71.5  1.9‡
SBEc (mMl) 2.8  0.9 13.4  0.7* 3.6  0.9 12.1  0.8
# 15.7  0.3†,‡
All values are expressed as means  se. pCO2, partial pressure of carbon dioxide; pO2, partial pressure of oxygen; sO2, plasma oxygen
saturation (fraction of oxyhemoglobin in deoxy-plus oxyhemoglobin of blood); HCO3
, bicarbonate; tCO2, total plasma carbon dioxide of
whole blood; SBEc, standardized base excess (concentration of titratable base). Ntg baseline, n 
 5; Tg baseline, n 
 5; Ntg CO2 (10 min), n 

5; Tg CO2 (10 min), n 
 6; Tg CO2 (20 min), n 
 5. *P  0.05 vs. Ntg baseline; t test.
#P  0.05 vs. Tg baseline, †P  0.05 vs. Tg CO2 (10 min),
‡P  0.05 vs. Tg baseline; one-way ANOVA.
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Figure 2. Radiotelemetry-based blood pressure recordings in vivo. a) Representative raw arterial pressure and heart rate
trace recording baseline circadian rhythms from Ntg and Tg mice over the course of 5 days. b) Mean systolic arterial
pressure (left), diastolic arterial pressure (middle), and heart rate (right) during a given 24 h of baseline analysis for Ntg
(f) and Tg () mice. c) Representative raw pressure traces during 40 min of exposure to 40% CO2 for Ntg and Tg mice.
d) Average change in systolic arterial blood pressure at baseline (f) and at the onset of acidosis (), illustrating the stress
response in both Ntg and Tg mice. e) Mean data for systolic and diastolic arterial pressure measurements between
nontransgenic (F) and transgenic (E) mice during the time course of hypercapnic acidosis. f) Change in mean arterial
pressure (MAP) from baseline to the completion of the hypercapnic acidosis challenge for Ntg (f) and Tg () mice.
Values are expressed as means  se. Two-way repeated-measures ANOVA main effects: ‡P  0.05 for time; †P  0.05 for
genotype. Two-way repeated measures ANOVA interaction effects: §P  0.05 for time vs. genotype; *P  0.05 for Ntg vs.
Tg. Ntg, n 
 4; Tg, n 
 7.
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To determine whether Tg mice were able to maintain
proper sinus rhythm during acidosis, we performed
continuous telemetered electrocardiographic measure-
ments during a 40-min hypercapnic acidosis challenge.
These data show that both Ntg and Tg mice experi-
enced intermittent extended R-R intervals associated
with sinus pause or sinus dysfunction throughout the
time course of hypercapnic acidosis (Supplemental Fig.
2). Overall, there was no difference in the frequency or
duration of this episodic sinus dysfunction between Ntg
and Tg mice during acidosis (Supplemental Fig. 2b, c).
Furthermore, core body temperature and heart rate
decreased similarly between Ntg and Ttg mice during
prolonged acidosis (Supplemental Fig. 2d, e). All mice
recovered from this 40-min hypercapnic acidosis chal-
lenge.
Assessment of cardiac function during -blockade
To directly assess cardiac hemodymanics, mice were
surgically instrumented by implantation of a conduc-
tance micromanometry catheter into the left ventricle.
After stabilization of cardiac function, baseline mea-
surements were acquired followed by an infusion of
esmolol (250 g/kg/min) to suppress adrenergic in-
volvement in the cardiac response to acidosis. Inferior
vena cava occlusions (IVCOs) were performed just
prior to the start and after 5 min of esmolol infusion to
acquire load-independent measures of contractility
(For full experimental protocol, see Supplemental Fig.
3). These data show that during the initial 5 min of
esmolol infusion, Ntg and Tg mice experienced a
slowing of the heart rate, left ventricular cavitary dila-
tion (e.g., increased LV max volume), a slight diminu-
tion in measures of contractility (e.g., systolic pressure,
dP/dt, contractility index, ejection fraction, and
stroke work) and evidence of marked slowing in dia-
stolic function [increased left ventricular end-diastolic
pressure (LVEDp) and Tau] (Figs. 3a, b and 4a).
However, contractile performance was significantly
better in cTnIA164H Tg than Ntg mice after 5 min of
esmolol infusion based on higher ejection fraction,
stroke work, and dP/dt (e.g., dP/dt 4603.7612
vs. 7094.1545 mmHg/s for Ntg and Tg; P0.05)
(Fig. 5a). Intrinsic inotropic function measured from
the slope of the end-systolic pressure-volume rela-
tionship (ESPVR; end-systolic pressure:end-systolic
volume) and preload recruitable stroke work (PRSW;
stroke work:end-diastolic volume) assessed load-inde-
pendent measures of contractility (acquired by PV
loop analysis during IVCO) (Fig. 5b). This analysis
showed a higher preload-independent inotropic ca-
pacity in Tg mice compared to Ntg mice at baseline
and during esmolol infusion. The negative derivative
of pressure development (dP/dt, data not shown),
end-diastolic pressure (EDp), and Tau were not
different between Ntg and Tg mice during esmolol
infusion, indicating comparable diastolic function
between these groups (Fig. 4a).
Cardiac function and survival during hypercapnic
acidosis with -blockade
We next tested the hypothesis that catecholaminergic
stimulation played a significant role in the survival
capacity of mice during the acute hypercapnic acido-
sis challenge. To address this, cardiac function was
assessed during acute acidosis without endogenous
-adrenergic support. Mice were instrumented with a
conductance micromanometry catheter and infused
with esmolol for 5 min (as described above) and then
exposed to 40% CO2 for 20 min with the esmolol
infusion continuing to the completion of the chal-
lenge (Supplemental Fig. 3). By pressure-volume
analysis, at the onset of respiratory hypercapnic
acidosis, Ntg mice underwent precipitous cardiac
decompensation within the first 5 min of acidosis
(Figs. 3a, b). In terms of inotropic function, this
decline in cardiac performance was characterized by
a sudden decrease in systolic pressure, ejection frac-
Figure 3. Raw data traces of real-time conduc-
tance micromanometry during hypercapnic aci-
dosis. a) Representative raw pressure-volume loops
(pressure bar
60 mmHg, volume bar
20 l) of
Ntg (gray) and Tg (black) mice during the time
course of an esmolol plus hypercapnic acidosis
challenge. Asterisk indicates time of death for Ntg
mouse. b) Representative raw traces of pressure
(top; bar
60 mmHg), volume (middle; bar
30
l), and pressure derivatives (bottom; bar
10,000
mmHg/s) for Ntg and Tg mice at baseline, during
infusion of esmolol (5 min), at 8 min into the
acidosis challenge, and at the end of the assay (25
min), illustrating changes in cardiac contractility
and geometry during the time course of this chal-
lenge. Time scale bar 
 0.2 s.
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tion, contractility index, and stroke work (Figs. 4 and
5a). Furthermore, diastolic dysfunction emerged
during the onset of acidosis (increased LVEDp and
Tau) together with further dilation of left ventricular
chamber geometry (Fig. 4).
In marked contrast, Tg mice showed sustained
cardiac function during this respiratory hypercapnic
acidosis challenge, even in the absence of -adrener-
gic support (Fig. 3a, b). These data represent a
transgene enhancement effect on the part of cTnI
A164H mice, which contributes to their survival
capacity compared to Ntg mice (Fig. 4b). More
specifically, Tg mice actually increased their devel-
oped pressure, made evident by an immediate in-
crease in end-systolic pressure (ESp) and, more
modestly, the positive derivative of pressure develop-
ment (dP/dt) and stroke work (Fig. 4a, b and 5a).
This was sustained until the latter phases of acidosis,
when LVESp decreased to slightly below baseline
values together with a drop in the dP/dt and stroke
work (Figs. 4a, b and 5a).
Other hemodynamic parameters of cardiac func-
tion for Tg mice in this group showed an initial
decrease during the onset of acidosis followed unex-
pectedly by a recovery toward baseline values during
the latter stages of acidosis (Fig. 4 and Table 1).
Similar to the echocardiography data, Table 1 shows
the restoration in function at the end of the chal-
lenge compared to measurements taken at the begin-
ning and at the nadir for parameters derived by
hemodynamic analysis. These measurements reveal
that function at the end of the challenge was not
significantly different than baseline in Tg mice.
During the onset of acidosis, measures of contractil-
ity decreased initially but returned toward baseline
during the latter phases of acidosis (e.g., from the
nadir contractility index increased by 21.126.5 U)
(Figs. 4a and 5a and Table 1). The contractility index
Figure 4. Summary of real-time in
vivo hemodynamic data. a) Sum-
marized mean data showing
changes in cardiac functional
and geometric parameters, in-
cluding systolic pressure, end-
diastolic pressure, dP/dt, con-
tractility index, ejection fraction,
maximum volume, Tau, heart
rate, and stroke work between
Ntg (F) and Tg (E) mice during
the time course of esmolol infu-
sion and acute hypercapnic aci-
dosis. b) Representative raw data
(derived from 5-s averages) of
end-systolic pressure, ejection
fraction, maximum volume, and
Tau during 20 min of esmolol
plus acidosis, showing transgene
enhancement (light gray) of
cTnI A164H. Values are ex-
pressed as means  se. Ntg, n 

6; Tg, n 
 7.
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(CI) is defined as the positive-pressure derivative
(dP/dt) normalized to the ventricular pressure at
that point. Taking this into consideration, this
change in CI is understood as the maintenance of the
positive-pressure derivative despite decreases in the
ESp during acidosis, suggestive of an overall increase
in contractility during this challenge. Diastolic func-
tion also increased initially but returned to baseline
values by the end of the challenge (e.g., from the
nadir LVEDp decreased in Tg mice 4.40.8 mmHg)
(Fig. 4 and Table 1). Similarly, ventricular dilation
occurred at the onset of acidosis followed by a
restoration of the ventricular chamber geometry
during the latter phases of hypercapnia (e.g., maxi-
mum volume decreased from the nadir in Tg mice
3.81.2 l) (Fig. 4a and Table 1). In all cases, the
absolute change between the nadir and the end of
the challenge for parameters given in Table 1 was
different from zero based on a Dunnet’s analysis,
showing a recovery of hemodynamic function during
acidosis in Tg mice. However, in stark contrast to the
functionality of Tg mice throughout this challenge,
the lowest point for Ntg mice was at the time of death
(Table 1). When assessed for survival, cTnI A164H
mice showed a significant transgene-mediated en-
hancement of cardiac function, while Ntg mice de-
velop severe cardiac dysfunction and pump failure in
response to hypercapnic acidosis with -adrenergic
blockade. The 100% survival of Tg mice compared to
100% failure in Ntg mice within 5 min of the onset of
acidosis is a striking indicator of the improved inotropy
caused by this single amino acid substitution (Fig. 6a, b).
DISCUSSION
Cardiomyopathies associated with myocardial acidosis
can result in profound systolic and diastolic dysfunc-
tion. Understanding mechanisms associated with pro-
tecting cardiac pump performance during acidosis are
important in developing therapies. This study reveals
whole animal responses in Tg mice expressing a single
histidine modified cardiac TnI during acute respiratory
hypercapnic acidosis. During hypercapnia, cTnI A164H
mice had a significantly greater capacity to maintain
cardiac geometry and function compared to Ntg mice.
Furthermore, in the absence of catecholaminergic sup-
port, Tg mice showed markedly improved survival vs.
Ntg mice. This outcome resulted from the ability of Tg
mice to maintain significantly higher intrinsic cardiac
function without compromising diastolic performance
compared to Ntg mice. Among studies seeking to
preserve pump function in disease (20, 22, 41), results
from the present study show a unique response of
improved systolic and diastolic performance during
acidosis in vivo. Overall, the results of this study illus-
trate that molecular manipulation of myofilament per-
formance by means of a histidine button engineered
Figure 5. Hemodynamic analysis of inotropic function during esmolol and acidosis. a) Mean data extracted at baseline, at
5 min after esmolol infusion, at 8 min into the acidosis challenge, and at the end of the protocol (25 min) showing a
significant difference between Ntg (f) and Tg () mice based on contractile properties, including systolic pressure,
dP/dt, ejection fraction, and contractile index. b) Load-independent measures of contractility acquired by IVCOs,
including end-systolic pressure volume relationship (ESPVR) and preload recruitable stroke work (PRSW), showing the
difference between Ntg (f) and Tg () mice at baseline and during infusion of esmolol. Insets: representative slopes for Ntg
and Tg mice. Values are expressed as means  se. Two-way repeated-measures ANOVA main effects: ‡P  0.05 for time; †P  0.05
for genotype. Two-way repeated measures ANOVA interaction effects: §P 0.05 for time vs. genotype; *P 0.05 for Ntg vs. Tg. Ntg,
n 
 6; Tg, n 
 7.
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into the switch region of cTnI results in significant
protection of cardiac geometry and function and im-
proved survival in the context of severe respiratory
hypercapnic acidosis in vivo.
Myofilament calcium sensitivity and acidosis
Elevated plasma CO2 occurs in numerous pathophysio-
logical contexts, such as severe COPD (42), conditions of
hypercarbic respiratory failure (43), respiratory infec-
tions (44), or congenital central hypoventilation
syndrome (45). A fundamental consequence of de-
creases in pH is the uncoupling of excitation-contrac-
tion (E-C) events, which are necessary for the tight
regulation of beat-to-beat pump activity in the heart
(5, 46). At the subcellular level, E-C uncoupling is
made evident by an acidosis-induced reduction in
force-generating capacity by the sarcomere for any
given [Ca2]i. Acidosis decreases both maximal
Ca2-activated tension and the Ca2 sensitivity of
tension (2, 20, 23, 31, 32, 47). Acidosis also decreases
myocyte maximal sarcomere length shortening am-
plitude and shortening velocity (20, 48, 49). These
experiments illustrate that myofilament Ca2 desen-
sitization at low pH is a fundamental molecular
deficiency responsible for cardiac organ pathologies
associated with myocardial acidosis (9). Notably,
results from this study demonstrate that cTnI A164H
works effectively to prevent this Ca2 desensitization
and provides a survival benefit to respiratory acidosis
in an intact animal model.
Adrenergic blockade and cTnI A164H performance
Sympathetic stimulation increases cardiac inotropy and
lusitropy. It has been shown that rodent hearts have
high -adrenergic tone under baseline conditions (20,
22). This may mask cardiomyopathies associated with
alterations in myofilament calcium handling (33). Con-
sequently, we addressed the role played by -adrenergic
signaling using a -blocker, esmolol, during hemody-
namic analysis to determine the intrinsic systolic and
diastolic properties of the cTnI A164H heart. Notably,
we found load-independent measures of contractility
were significantly higher in Tg vs. Ntg mice under
-blockade, suggesting a higher intrinsic capacity for
contractile function in cTnI A164H Tg mice. Hemody-
namic measurements obtained in this study demon-
strate the first evidence that cTnI A164H mice can
maintain cardiac function during acidosis in vivo.
Although enhanced systolic function is expected with
this model, diastolic function (e.g., Tau, EDp) can be
problematic for Tg mouse models expressing altered
myofilament proteins. For example, calcium-sensitizing
models show diastolic dysfunction, such as cTnI R193H
(34), cTnT R92Q (51), and ssTnI mice in vivo (35).
Notably, this study shows that, in the absence of sym-
pathetic activity, baseline diastolic function of cTnI
A164H Tg mice is not different from the Ntg cohort.
cTnI A164H: a titratable myofilament inotrope
Multiple investigators have proposed that targeting
myofilament calcium responsiveness via manipulation
of TnC and TnI interactions is desirable for protecting
cardiac function during acidosis (20, 22, 30, 41, 51–53).
However, previous approaches have found that en-
hancement of systolic function often concomitantly
results in diastolic dysfunction, as discussed above. For
example, Tg mice expressing ssTnI show improved
cardiac function during acidosis (22). However, they
also show significant diastolic dysfunction during this
challenge (22, 35), and more generally, these hearts
lack the ability to modulate TnI function via PKA
activation by -adrenergic signaling. Pharmacological
alterations of the myofilament using TnC Ca2 sensitiz-
ers, such as levosimendan, also improve inotropy (41,
54–56) but have significant non-TnC actions. In con-
trast, the present study shows that cTnI A164H is
capable of improving myofilament function in response
to acidosis, without concomitant diastolic dysfunction,
alterations in -adrenergic signaling, or nonspecific
effects on myocyte function.
The underlying biochemistry of a histidine button
engineered into TnI provides insights into potential
mechanisms supporting this concept. Specifically, his-
tidine ionizes near physiological pH with a pKR around
Figure 6. Survival data during respiratory hypercapnic acido-
sis. a) Representative raw data (derived from 5-s averages) for
ESp over the full time course of the experimental protocol,
including esmolol infusion followed by CO2 ventilation for
Ntg and Tg mice. b) Survival curve showing the time of pump
failure for Ntg mice, which occurred after the onset of ventilation
with 40% CO2 compared to the 100% survival of Tg mice after 25
min of exposure to this challenge. Ntg, n 
 6; Tg, n 
 7.
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6.0. Consequently, under mildly acidic conditions the
increasing propensity for the ionization of histidine
changes the biochemical function of surrounding resi-
dues and any interactions mediated by this region of
the protein. In cardiac troponin I, this histidine substi-
tution (A164H) is positioned in the regulatory domain
between the amphiphilic switch region (helix 3) and
the C-terminal actin binding domain (helix 4). Previ-
ous studies have shown that this region is critically
involved in the interaction between TnI and TnC
during systole through the electrostatic binding of the
switch region of TnI with the calcium-saturated N-
terminal hydrophobic patch of TnC (57–61). Although
further studies are required to address the specific
biophysical consequences of these potential interac-
tions, the physiological implications of this histidine
modification have been reported by this and other
studies (20). We propose that cTnI A164H acts as a
molecular rheostat maintaining systolic and diastolic
pump function in models of severe acidosis and isch-
emic cardiomyopathy in vitro and in vivo.
This study contributes new evidence that shows a
potential therapeutic role of cTnI A164H in the heart.
Specifically, evidence from these experiments demon-
strates a marked transgene enhancement effect that
confers protection from acidosis-induced pump failure
and death in living animals. We hypothesize that this
response is mediated foremost by the underlying bio-
chemistry of the histidine-modified cTnI acting as a
molecular rheostat of the intracellular milieu. This
study contributes to the growing evidence that histi-
dine-modified troponin I is an effective target protein
for the protection of cardiac performance during se-
vere acidosis in vivo.
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